Dawn-bio ApS
CVR 43849662 · Private limited company (ApS) · Active · Low risk
Dawn-bio ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 3 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -3.4m and a net result of DKK -1.1m. CEO: Alok Javali.
Bankruptcy risk for Dawn-bio ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43849662
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- LPOG ApS
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 3 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -338.2% |
| Current ratio | 628% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -638k | DKK -1.2m | DKK -562k |
| Net profit | DKK -1.1m | DKK -1.6m | DKK -785k |
| Equity | DKK -3.4m | DKK -2.3m | DKK -745k |
| Total assets | DKK 1.0m | DKK 2.0m | DKK 3.4m |
| Cash | DKK 400k | DKK 462k | – |
| Short-term debt | DKK 108k | DKK 110k | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · LPOG ApS.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 169 | ||
| 1 Jan 2024 – 31 Dec 2024 | 146 | ||
| 13 Feb 2023 – 31 Dec 2023 | 176 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Alok Javali | Current | |
| Owner (100%) | dawn-bio GmbH | Current | |
| Founder | Alok Javali | Current | |
| Founder | TH Investment GmbH | Current | |
| Founder | Nicolas Clément Rivron | Current |
Address history (0 moves)
| Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Dawn-bio ApS
Has Dawn-bio ApS gone bankrupt?
No, Dawn-bio ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Dawn-bio ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Dawn-bio ApS?
Alok Javali is the CEO of Dawn-bio ApS.
Who is the auditor of Dawn-bio ApS?
Dawn-bio ApS most recently used LPOG ApS.
When was Dawn-bio ApS founded?
Dawn-bio ApS was founded on 13 February 2023.
What is the equity of Dawn-bio ApS?
Equity was DKK -3.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.